XML 26 R15.htm IDEA: XBRL DOCUMENT v3.8.0.1
WARRANT AGREEMENTS
9 Months Ended
Sep. 30, 2017
Notes to Financial Statements  
Note 10 - Warrant Agreements

On January 3, 2017, the Company issued 1,300,000 warrants in connection with commissions earned in relation to the Company’s Private Label Exclusive Distribution and License agreement with Red Barn Pet Products, LLC.

 

From May 11, 2017 to September 30, 2017, the Company issued 260,000 warrants in connection with the issuance of $1,300,000 convertible promissory notes.

 

Warrants that vest at the end of a one-year period are amortized over the vesting period using the straight-line method.

  

The Company’s warrant activity was as follows:

 

    Warrants    

Weighted Average

Exercise Price

    Weighted Average Contractual Remaining Life  
Outstanding, December 31, 2016     4,392,107       1.97       6.17  
Granted     1,560,000       2.83       0.67  
Exercised     -       -       -  
Forfeited/Expired     -       -       -  
Outstanding, September 30, 2017     5,952,107       2.19       4.18  
Exercisable at September 30, 2017     3,750,665       2.34       2.70  

 

The change in warrant value for the three and nine months ended September 30, 2017 was ($157,013) and $2,560,607, respectively. The change in warrant expense for the three and nine months ended September 30, 2016 was $0.

 

Range of

Exercise Price

 

Number of

Warrants

    Weighted Average Remaining Contractual Life (years)     Weighted Average Exercise Price     Number of Warrants Exercisable     Weighted Average Exercise Price  
$1.00 - $7.00     5,952,107       4.18     $ 2.19       3,750,665     $ 2.34  
      5,952,107       4.18     $ 2.19       3,750,665     $ 2.34  

 

The weighted-average fair value of warrants granted to during the three months ended September 30, 2017 and year ended December 31, 2016, and the weighted-average significant assumptions used to determine those fair values, using a Black-Scholes-Merton (“Black-Scholes”) option pricing model are as follows:

 

   

September 30,

2017

   

December 31,

2016

 
Significant assumptions (weighted-average):            
Risk-free interest rate at grant date     1.92 %     1.83 %
Expected stock price volatility     84.43 %     84.42 %
Expected dividend payout     -       -  
Expected option life (in years)     3       3  
Expected forfeiture rate     0 %     0 %